A new Richmond-based pharmaceutical manufacturing company has received a $354 million federal contract to make the active ingredients for more than a dozen medicines used to treat patients with COVID-19.
And the ingredients will be made at a pharmaceutical plant in Petersburg, which could create about 350 jobs.